InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3066% above fair value
$9.58+0.11 (+1.16%)
Close on Nov 16, 2026Market cap $1.31BP/E –Yield –
InnovAge total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
InnovAge's total debt was $48.06M at Jun 30, 2026. For fiscal 2026 it was $48.06M, down 19.5% from the year before. The highest annual figure on record is $212.37M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $48.06M | -19.5% |
| FY2025 | Jun 30, 2025 | $59.71M | -8.5% |
| FY2024 | Jun 30, 2024 | $65.27M | -4.9% |
| FY2023 | Jun 30, 2023 | $68.64M | -4.7% |
| FY2022 | Jun 30, 2022 | $72.00M | -4.5% |
| FY2021 | Jun 30, 2021 | $75.36M | -64.5% |
| FY2020 | Jun 30, 2020 | $212.37M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $48.06M | -19.5% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $57.97M | -7.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $58.53M | -8.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $59.16M | -8.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $59.71M | -8.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $62.75M | -5.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $63.59M | -5.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $64.43M | -5.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $65.27M | -4.9% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $66.12M | -4.8% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $66.96M | -4.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $67.80M | -4.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $68.64M | -4.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $69.48M | -4.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $70.32M | -4.6% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $71.16M | -4.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $72.00M | -4.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $72.84M | -3.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $73.68M | -65.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $74.52M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $75.36M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $75.27M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $212.37M | – |
See a number that looks wrong?